- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07593729
Nurse-Led Caregiver Support Program in Home Palliative Care (CARE-PAL)
Effect of a Nurse-Led Caregiver Support Program on Caregiver Competency and Healthcare Utilization Among Family Caregivers in Home Palliative Care: A Randomized Controlled Trial
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Palliative care aims to improve quality of life for individuals with life-threatening illnesses through symptom management and holistic care. In home palliative care settings, family caregivers play a critical role in providing daily care and symptom monitoring. However, caregiving responsibilities may lead to increased burden, stress, and inappropriate healthcare utilization.
This study is designed as a single-center, parallel-group, randomized controlled trial to evaluate the effectiveness of a nurse-led caregiver support program among family caregivers of patients receiving home palliative care services.
A total of 150 family caregivers will be recruited and randomized into intervention and control groups in a 1:1 ratio using computer-generated block randomization. Participants in the intervention group will receive a structured 6-week nurse-led caregiver support program consisting of an initial face-to-face educational session and weekly telephone coaching. Intervention content includes symptom management, daily care skills, medication management, complication recognition, caregiver self-care, stress management, and healthcare utilization decision support. Caregivers will also receive a caregiver guidebook and crisis management decision algorithm.
Participants in the control group will continue receiving routine home palliative care services without additional structured support.
Outcome assessments will be conducted at baseline (T0), post-intervention (T1), and 3-month follow-up (T2). The primary outcome is caregiver competency measured using the Care Competency Scale for Family Caregivers in Home Palliative Care. Secondary outcomes include caregiver burden, self-efficacy, patient symptom burden, emergency department visits, and hospitalizations.
The study is expected to provide evidence regarding the effectiveness of nurse-led caregiver support interventions in home palliative care settings.
Typ studiów
Zapisy (Szacowany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Serkan Budak, PhD / RN
- Numer telefonu: +905385430616
- E-mail: serkan.budak@ksbu.edu.tr
Lokalizacje studiów
-
-
Kütahya
-
Simav, Kütahya, Turcja (Türkiye), 43500
- Rekrutacyjny
- Simav Doc. Dr. Ismail Karakuyu State Hospital
-
Kontakt:
- Veli Arslan, RN
- Numer telefonu: +902745137048
- E-mail: kutahyadhs10@saglik.gov.tr
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dorosły
- Starszy dorosły
Akceptuje zdrowych ochotników
Opis
Inclusion Criteria:
- Adult family caregivers of patients receiving home palliative care services
- Age 18 years or older
- Being the primary caregiver responsible for the patient's daily care
- Ability to communicate in Turkish
- Willingness to participate in the study
Exclusion Criteria:
- Professional or paid caregivers
- Caregivers with severe cognitive impairment or severe psychiatric disorders
- Inability to participate in follow-up assessments
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Nurse-Led Caregiver Support Program
Participants will receive a structured nurse-led caregiver support program in addition to routine home palliative care services.
|
Participants in the intervention group will receive a structured 6-week nurse-led caregiver support program including face-to-face education, weekly telephone coaching, caregiver guidance materials, symptom management support, medication management education, stress management strategies, and healthcare utilization decision support in addition to routine home palliative care services.
|
|
Brak interwencji: Routine Home Palliative Care
Participants will receive routine home palliative care services.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Care Competency Scale for Family Caregivers in Home Palliative Care
Ramy czasowe: Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
Caregiver competency will be assessed using the Care Competency Scale for Family Caregivers in Home Palliative Care.
The scale includes 29 items scored on a 1-5 Likert scale.
Total scores range from 29 to 145, with higher scores indicating greater caregiver competency.
|
Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Zarit Burden Interview
Ramy czasowe: Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
Caregiver burden will be assessed using the Zarit Burden Interview.
Total scores range from 0 to 88, with higher scores indicating greater caregiver burden.
|
Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
|
General Self-Efficacy Scale
Ramy czasowe: Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
Caregiver self-efficacy will be assessed using the General Self-Efficacy Scale.
Total scores range from 10 to 40, with higher scores indicating greater self-efficacy.
|
Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
|
Integrated Palliative Care Outcome Scale
Ramy czasowe: Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
Patient symptom burden will be assessed using the Integrated Palliative Care Outcome Scale proxy version.
Total scores range from 0 to 68, with higher scores indicating greater symptom burden and unmet needs.
|
Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
|
Emergency Department Visits
Ramy czasowe: Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
Emergency department visits will be assessed as the number of emergency department visits during the follow-up period.
Higher values indicate greater emergency healthcare utilization.
|
Baseline, post-intervention at 6 weeks, and 3-month follow-up
|
|
Hospitalizations
Ramy czasowe: During the 3-month follow-up period
|
Hospitalizations will be assessed as the number of hospital admissions during the follow-up period.
Higher values indicate greater inpatient healthcare utilization.
|
During the 3-month follow-up period
|
Współpracownicy i badacze
Publikacje i pomocne linki
Publikacje ogólne
- Karabulutlu EY, Turan GB, Yanmis S. Evaluation of care burden and preparedness of caregivers who provide care to palliative care patients. Palliat Support Care. 2022 Feb;20(1):30-37. doi: 10.1017/S1478951521000213.
- Wang T, Kong J, Chen X, Yang Y, Liu D, Liu T, Li L. Development and psychometric assessment of a care competency scale for family caregivers in home palliative care. Asia Pac J Oncol Nurs. 2025 May 10;12:100719. doi: 10.1016/j.apjon.2025.100719. eCollection 2025 Dec.
- Zhang Y, Li J, Zhang Y, Chen C, Guan C, Zhou L, Zhang S, Chen X, Hu X. Mediating effect of social support between caregiver burden and quality of life among family caregivers of cancer patients in palliative care units. Eur J Oncol Nurs. 2024 Feb;68:102509. doi: 10.1016/j.ejon.2024.102509. Epub 2024 Jan 15.
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- KSBU-HPC-RCT-2026-01
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .